Condensed Consolidated Statement of Shareholders’ Equity - USD ($) $ in Thousands	Total	Common Shares	Treasury Shares	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2024		29,195,439
Beginning balance at Dec. 31, 2024	$ 53,095	$ 420,364	$ (2,854)	$ 76,992	$ (444,692)	$ 3,285
Beginning balance, treasury stock (in shares) at Dec. 31, 2024			(408,070)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common shares in lieu of cash compensation (in shares)		90,153
Issuance of common shares in lieu of cash compensation	4,062	$ 4,062
Stock option exercises (in shares)		4,260
Stock option exercises	79	$ 79
Share-based compensation (in shares)		33,530
Share-based compensation	2,434	$ 34		2,400
Shares withheld to cover income tax obligation upon vesting of restricted stock (in shares)		(6,975)
Shares withheld to cover income tax obligation upon vesting of restricted stock	(282)	$ (7)		(275)
Foreign currency translation loss (gain)	(128)					(128)
Net loss	(20,710)				(20,710)
Ending balance (in shares) at Mar. 31, 2025		29,316,407
Ending balance at Mar. 31, 2025	$ 38,550	$ 424,532	$ (2,854)	79,117	(465,402)	3,157
Ending balance, treasury stock (in shares) at Mar. 31, 2025			(408,070)
Beginning balance (in shares) at Dec. 31, 2025	29,304,954	29,713,024
Beginning balance at Dec. 31, 2025	$ 23,547	$ 433,378	$ (2,854)	87,624	(495,756)	1,155
Beginning balance, treasury stock (in shares) at Dec. 31, 2025	(408,070)		(408,070)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common shares in lieu of cash compensation (in shares)		1,716
Issuance of common shares in lieu of cash compensation	$ 97	$ 97
Stock option exercises (in shares)	32,607	32,607
Stock option exercises	$ 1,008	$ 1,008
Share-based compensation (in shares)		56,385
Share-based compensation	3,003	$ 56		2,947
Shares withheld to cover income tax obligation upon vesting of restricted stock (in shares)		(10,651)
Shares withheld to cover income tax obligation upon vesting of restricted stock	(702)	$ (10)		(692)
Foreign currency translation loss (gain)	1,212					1,212
Net loss	$ (13,382)				(13,382)
Ending balance (in shares) at Mar. 31, 2026	29,385,011	29,793,081
Ending balance at Mar. 31, 2026	$ 14,783	$ 434,529	$ (2,854)	$ 89,879	$ (509,138)	$ 2,367
Ending balance, treasury stock (in shares) at Mar. 31, 2026	(408,070)		(408,070)

ESTABLISHMENT LABS HOLDINGS INC. 10-Q